Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | LY4257496 |
| Trade Name | |
| Synonyms | LY-4257496|LY 4257496 |
| Drug Descriptions |
Limited information is currently available on LY4257496, a putative radioligand therapy targeting GRPR (Aug 2025). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abemaciclib + LY4257496 | Abemaciclib LY4257496 | 0 | 0 |
| Capecitabine + LY4257496 | Capecitabine LY4257496 | 0 | 0 |
| Fulvestrant + LY4257496 | Fulvestrant LY4257496 | 0 | 0 |
| Imlunestrant + LY4257496 | Imlunestrant LY4257496 | 0 | 0 |
| LY4257496 | LY4257496 | 0 | 0 |